ClinicalTrials.gg
Sign In

Biological

Personalized Peptide Cancer Vaccine NEO-PV-01 clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2016

How studies write it

Studies that test it under each name

Name

NEO-PV-01
3

Studies by the year they started

3 studies that test it; most in 2018 (2)

Studies that test Personalized Peptide Cancer Vaccine NEO-PV-01, by start year
YearStudies
20161
20182

By phase

A phase 1/2 study counts in both.

Phase 1
3

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Transitional Cell
1
Melanoma
1

Who runs them

Industry 3 · Other 0

BioNTech US Inc. (3)

Often tested with

Tested in the same studies.

Pembrolizumab (1) · Nivolumab (1) · Sotigalimab (1) · Ipilimumab (1)

Studies

Open first, then newest update. How each study uses Personalized Peptide Cancer Vaccine NEO-PV-01 is read from its arms, and is right about nine times in ten.

Testing it · 3